[6] Heidegger I,KlockerH,Pichler R et al. ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study.[J] .Prostate Cancer Prostatic Dis, 2017, 20: 271-27...
"However, PSA blood tests are not routinely used to screen for prostate cancer, as results can be unreliable. "Only about a quarter of people who have a prostate biopsy due to an elevated PSA level are found to have prostate cancer. "There has therefore been a drive to create a new blo...
2. Surveillance, Epidemiology and End Results . Cancer stat facts: prostate cancer. https://seer.cancer.gov/statfacts/html/prost.html 3. Dess RT, Hartman HE, Mahal BA et al. Association of black race with prostate ...
Results: After a median follow-up of 18.9 years, 754 men (14.6%) were diagnosed with prostate cancer (PC). The overall cumulative PC incidence was 17.2%. It increased from 7.9% among men with T-PSA of ≤0.99 ng/mL to 26.0% in men with T-PSA levels of 1–1.99 ng/mL and ...
[3] 1.Chi K M, et al. Final analysis results from TITAN: a phase 3 study of apalutamide vs placebo in patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy. J Clin Oncol 39, 2021 (suppl 6; abstr 11). ...
我们从美国Surveillance, Epidemiology, and End Results program(SEER)数据库收集了于2010年到2015年间诊断为原发神经分泌前列腺癌的患者的临床特征及预后资料。由于已有的研究表明50%-60%的原发神经分泌前列腺癌为单纯神经分泌前列腺癌(Pure neuroendocrine prostate cancer, Pure NEPC),其余的为前列腺癌伴随神经内分泌分...
The results are important, because if they show that your PSA level rises quickly, you may need different treatment. Your prostate makes PSA. So do most prostate cancer cells. During prostate cancer treatment, changes in your PSA levels help show whether your treatment is working. ...
[1]Chi K M, et al. Final analysis results from TITAN: a phase 3 study of apalutamide vs placebo in patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy. J Clin Oncol 39, 2021 (suppl 6; abstr 11). ...
That’s Correct. PSA results are without merit in testing for prostate cancer. However, from the way we have been commonly educated, I have seen men go into an absolute panic...
These results suggest that the majority of PSA+ PCa cells are high in AR, whereas PSA−/lo cells express a gradient of AR, from completely negative to strong nuclear staining. PSA−/lo LNCaP Cells Preferentially Express Antistress Genes and Are Resistant to Androgen Deprivation, ...